Clinical trials: Venom Allergy, open to volunteers
Vespid Venom Allergy
Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)
Insect venom allergy is the major cause for severe allergic reactions in Europe. Wasps and honeybees are responsible for the majority of these allergic reactions.
- Trial name
- NCT04438525
- Testing
- sting challenge, blood donation
- Where
- Austria
- Volunteers
- 219 people
- Sponsor
- Medical University of Graz
Bee Venom Allergy
Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure
Venom immunotherapy (VIT) is an established treatment for Hymenoptera venom allergy and provides long-term protection from further generalized reactions in almost all patients.
- Trial name
- PREDICT (NCT04259359)
- Testing
- Insect Venom
- Where
- 3 sites in Austria, Germany and 1 more
- Volunteers
- 266 people
- Sponsor
- Medical University of Graz
Allergy, Immunotherapy
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Jack Jumper ant (JJA) venom allergy is a uniquely Australian medical condition. It is the leading cause of venom allergy and affects up to three per cent of the population.
- Conditions
- Allergy, Immunotherapy, Venom Allergy
- Trial name
- JAVELIN (NCT06935890)
- Testing
- Jack Jumper Ant Venom Immunotherapy
- Where
- 3 sites in Australia
- Volunteers
- 100 people
- Sponsor
- Murdoch Childrens Research Institute
Pollen Allergy, Venom Allergy
Identification of B Regulatory Cells by Flow Cytometry
The goal of this laboratory and observational study is to develop a test to quantify B-regulatory cells in blood. This will be used to detect changes in B-regulatory cell populations in pollen and insect venom allergic patients…
- Trial name
- NCT06876506
- Testing
- Venepuncture, Allergen Specific Immunotherapy
- Where
- United Kingdom
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Hull University Teaching Hospitals NHS Trust
Hymenoptera Venom Allergy
Virtual-reality Induced Immune Modulation in Allergic Patients
This study investigates whether immersive virtual reality (VR) exposure to allergen-related stimuli can modulate behavioural, neurophysiological, psychophysiological, and immune responses in adults with bee or wasp venom allergy.
- Trial name
- NCT07721233
- Testing
- Allergen-related immersive virtual reality exposure, Control immersive virtual reality exposure
- Volunteers
- 81 people, healthy volunteers welcome
- Sponsor
- University of Geneva, Switzerland
Anaphylaxis, Mastocytosis
Analysis of the Role of IgE Proteoforms in Health and Disease
The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of…
- Conditions
- Anaphylaxis, Mastocytosis, X-linked Agammaglobulinaemia, Venom Allergy
- Trial name
- IgE-PhD (NCT07328178)
- Testing
- Blood sample collection
- Where
- Belgium
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- KU Leuven
Allergy, Insect Venom, Allergy Insect Stinging
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
Observational study to evaluate the safety of immunotherapy as a treatment for Hymenoptera venom allergy, analyzing the adverse reaction to immunotherapy as well as the allergic reaction to a spontaneous hymenoptera sting.
- Conditions
- Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
- Trial name
- NCT06782217
- Testing
- VENOX
- Where
- 9 sites in Spain
- Volunteers
- 120 people
- Sponsor
- Inmunotek S.L.
Allergy, Insect Venom, Allergy Insect Stinging
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings.
- Conditions
- Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
- Trial name
- Venox-23 (NCT06790368)
- Testing
- VENOX
- Where
- 3 sites in Spain
- Volunteers
- 80 people
- Sponsor
- Inmunotek S.L.